AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
More news

Cancer

20 stories about Cancer
קרן אמון מימין ד"ר תומר ברקוביץ ד"ר יאיר שינדל טוד סון איציק דבש

Israel’s aMoon fund saw a 15-fold return on its investment in Seer

09.12.20|Sophie Shulman
aMoon invested in the U.S. biomed company when it was valued at $228 million- after a Nasdaq IPO, its value ballooned to $3.5 billion
ביופסיה לימקה מדיקל 2

Limaca Medical raises $1.25 million for precision biopsy device

11.11.20|Yafit Ovadia
The medical device company’s solution refines ultrasound-guided biopsies to improve tumor detection and other cancer diagnoses
מימין תומר קריב ו רן נוסבאום מנהלי קרן פונטיפקס

Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold

12.10.20|Tzally Greenberg
A series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
Joseph Mossel

Israel’s Ibex Medical Analytics Deploys in Puerto Rico, establishing a foothold in the Americas

01.09.20|James Spiro
Its Galen Prostate solution helps pathologists with more accurate diagnoses and improves lab efficiency
מוסף שבועי 6.8.20 אנשי חברת שיגור הלוויינים אריאן ליד הטיל שצוייד בלוויין של ספייס פארמה יוני 2020

The cure is out there: Miniature space labs are leading to scientific breakthroughs

08.08.20|Yoghev Carmel
From attempts to crack the aging process to developing asthma medicine, the most innovative medical experiments are taking place these days in space
Nectin and aMoon teams

Israeli healthtech VC aMoon Velocity invests $6 million in Nectin Therapeutics

15.07.20|James Spiro
Nectin Therapeutics places antibodies in proteins known to cause cancer, improving immune systems and blocking certain checkpoints
צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

AI cancer treatment startup Nucleai raises $6.5 million in series A round

07.07.20|Meir Orbach
Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment
מימין נועם סולומון ו לואיס וולוך

Immunai Announces $20 Million Seed Round to Fund Immune System Mapping

14.05.20|Hagar Ravet
The company employs more than 30 workers in Israel and New York and collaborates with more than 10 world-leading medical centers and bio-pharma companies
רחובות החדשה זירת הנדל"ן

Cancer Immunotherapy Startup NeoTX Raises $45 Million

20.02.20|Adi Pick
NeoTX uses STR to bind genetically engineered bacteria to tumor cells and simultaneously activate the antibacterial response of distant immune cells
מוסף תרופה תרופות בית מרקחת

Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns

16.02.20|Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%
רינת רותם דוקטור סמנכלית מחקר ו פיתוח קיורטק מוטי חכם סמנכל כספים קיורטק בשיער לבן

CureTech’s Cancer-Fighting Dreams End With Insolvency

03.02.20|Lital Dobrovitsky
After an acquisition deal with pharmaceutical company InSight fell through in 2018, the company failed to secure further funding
מוסף 3.5.18 בית חולים איכילוב תל אביב

Israel to Establish National Center for Proton Radiation Cancer Therapy

27.01.20|Adrian Filut
The Tel Aviv Sourasky Medical Center (Ichilov Hospital) has been chosen to operate the center, the construction of which is estimated at between $50 million and $100 million
פיליפ סרלין ביוליין

BioLineRx’s Flagship Pancreas Cancer Drug Receives Orphan Drug Status in Europe

15.01.20|Tzally Greenberg
The clinical stage company’s drug received a similar designation in the U.S. last year
מוסף שבועי 2.1.20 פרופ' אבי שרודר

God Willing, He Will Cure Cancer, and Shrimp

10.01.20|Yoghev Karmel
At 43, Technion researcher Avi Schroeder is a phenomenon with four startups under his belt, working to cure cancer with elephant protein and trying to personalize chemotherapy. In between, the kosher-keeping Yeshiva graduate is taking on a deadly shrimp plague
סרטן שד גידול הקפאה אייסקיור

IceCure Receives Additional FDA Clearance For Its Cancer Freezing Technology

07.01.20|Adi Pick
IceCure develops an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor, freezing its tissue in a process called cryoablation
מרסל מחלוף

Life Sciences Venture Fund aMoon Invests $5 Million in Cancer Drug Company

24.12.19|Hagar Ravet
NanoGhosts turns stem cells into a drug delivery system that specifically targets cancerous tumors
metabomed סימונה בוטי

Cancer Metabolism Company Metabomed Raises $12.5 Million

19.12.19|Adi Pick
The company develops cancer-fighting drugs that specifically target the reprogrammed cancer cells’ metabolism to halt their growth
רופא מומחה קופת חולים קופות חולים מחלה

7 Startups for Prostate Health

03.11.19|Adi Pick and Elham Nasser Eddin
In the U.S. alone, about 174,650 new cases of prostate cancer will have been diagnosed in 2019 and around 31,620 people will have died from the disease
סרטן שד גידול הקפאה אייסקיור

Cancer Freezing Company IceCure Signs Partnership With Oregon Hospitals

16.10.19|Adi Pick
IceCure’s device injects liquid nitrogen into a tumor, freezing the tumor tissue
סרטן שד גידול הקפאה אייסקיור

Tokyo-Listed Terumo Signs Distribution Deal With Cancer Freezing Company IceCure

01.09.19|Adi Pick
IceCure develops an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor, freezing its tissue in a process called cryoablation
Previous ArticlesMore Articles